Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incidence of Adrenal Insufficiency in Diffuse Large B-cell Lymphoma Patients after the 5th Chemotherapy Cycle with High-Dose Corticosteroid
TCTR20211125004Recruiting
- Sponsor
- Siriraj Hospital
- Start
- Mar 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in diffuse large B-cell lymphoma (DLBCL) and hypoadrenocorticism, sponsored by Siriraj Hospital. Primary endpoint: Incidence of adrenal insufficiency. Started Mar 2019; status: recruiting.
02
Conditions
diffuse large B-cell lymphoma (DLBCL)hypoadrenocorticism
Beyond the preview
Go deeper on TCTR20211125004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211125004.